Stock FRAGUA B CORPORATIVO FRAGUA, S.A.B. DE C.V.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Corporativo Fragua, S.A.B. de C.V.

Equities

FRAGUA B

MXP321131015

Drug Retailers

End-of-day quote Mexican S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
761 MXN +0.40% Intraday chart for Corporativo Fragua, S.A.B. de C.V. +1.46% +52.19%
Apr. 22 Corporativo Fragua, S.A.B. de C.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Corporativo Fragua, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2024 2025 2026
Capitalization 1 23,923 26,244 33,061 33,429 73,638 - -
Enterprise Value (EV) 1 23,368 24,215 30,708 27,704 65,309 63,420 61,408
P/E ratio 14.7 x 13.6 x 13.3 x 11.1 x - - -
Yield 1.18% - 3% - - - -
Capitalization / Revenue 0.39 x 0.36 x 0.39 x 0.34 x 0.61 x 0.55 x 0.51 x
EV / Revenue 0.38 x 0.33 x 0.36 x 0.28 x 0.54 x 0.48 x 0.42 x
EV / EBITDA 6.23 x 5.09 x 4.89 x 3.58 x 6.41 x 5.52 x 4.82 x
EV / FCF 179 x 14.8 x 49.4 x - 18.4 x 16.1 x 14 x
FCF Yield 0.56% 6.77% 2.02% - 5.43% 6.22% 7.15%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 97,646 97,396 97,396 97,156 96,771 - -
Reference price 2 245.0 269.5 339.4 344.1 761.0 761.0 761.0
Announcement Date 2/26/20 2/26/21 2/23/22 2/27/23 - - -
1MXN in Million2MXN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2024 2025 2026
Net sales 1 61,884 73,314 84,794 97,918 121,662 133,483 145,784
EBITDA 1 3,751 4,759 6,281 7,730 10,187 11,488 12,742
EBIT 1 3,028 3,880 5,217 6,315 8,781 9,938 11,047
Operating Margin 4.89% 5.29% 6.15% 6.45% 7.22% 7.45% 7.58%
Earnings before Tax (EBT) 2,633 3,367 4,670 5,602 - - -
Net income 1 1,710 2,030 2,622 - 4,683 5,153 5,669
Net margin 2.76% 2.77% 3.09% - 3.85% 3.86% 3.89%
EPS 16.67 19.78 25.55 30.99 - - -
Free Cash Flow 1 130.6 1,639 621 - 3,548 3,946 4,388
FCF margin 0.21% 2.24% 0.73% - 2.92% 2.96% 3.01%
FCF Conversion (EBITDA) 3.48% 34.45% 9.89% - 34.83% 34.35% 34.44%
FCF Conversion (Net income) 7.64% 80.75% 23.69% - 75.76% 76.58% 77.4%
Dividend per Share 2.900 - 10.20 - - - -
Announcement Date 2/26/20 2/26/21 2/23/22 2/27/23 - - -
1MXN in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3
Net sales 1 22,253 21,912 23,487 23,757 24,451 26,223 27,087 27,251
EBITDA 1 1,687 1,800 1,869 1,815 2,204 2,150 2,051 2,273
EBIT - - - - - - - -
Operating Margin - - - - - - - -
Earnings before Tax (EBT) - - - - - - - -
Net income 1 681.3 703.4 - 762.7 826 840 1,038 1,212
Net margin 3.06% 3.21% - 3.21% 3.38% 3.2% 3.83% 4.45%
EPS 2 6.640 6.850 7.310 7.430 8.050 8.180 10.12 11.82
Dividend per Share - - - - - - - -
Announcement Date 10/28/21 2/23/22 4/29/22 7/27/22 10/28/22 2/27/23 7/27/23 10/26/23
1MXN in Million2MXN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 555 2,029 2,353 5,725 8,329 10,218 12,230
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 131 1,639 621 - 3,548 3,946 4,388
ROE (net income / shareholders' equity) 12.9% 13.7% 15.8% 30.8% 21.5% 20.9% 20.5%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share 21.00 28.00 23.30 - - - -
Capex 2,027 1,553 1,767 - - - -
Capex / Sales 3.27% 2.12% 2.08% - - - -
Announcement Date 2/26/20 2/26/21 2/23/22 2/27/23 - - -
1MXN in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
761 MXN
Average target price
834 MXN
Spread / Average Target
+9.60%
Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.19% 4.29B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.21% 15.27B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 6.06B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.14% 6.04B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.86B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.88% 4.71B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.31% 3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-14.86% 3.33B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-6.93% 3.01B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. FRAGUA B Stock
  4. Financials Corporativo Fragua, S.A.B. de C.V.